Skip to main content


Placeholder slot

This page contains brief information about olaparib (Lynparza) and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Olaparib is approved to treat:

Olaparib is also being studied in the treatment of other types of cancer.

More About Olaparib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Olaparib - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Targeted Cancer Therapies

Can an Antibiotic Treat Cancers that Become Resistant to PARP Inhibitors?

With Two FDA Approvals, Prostate Cancer Treatment Enters the PARP Era

PARP Inhibitors Show Promise as Initial Treatment for Ovarian Cancer

Trial Highlights Complexities of Targeted Therapy for Pancreatic Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Olaparib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: